Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
about
Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@ast
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@en
type
label
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@ast
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@en
prefLabel
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@ast
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@en
P2093
P2860
P356
P1433
P1476
Tomotherapy as an adjuvant tre ...... umetric-modulated arc therapy.
@en
P2093
Gui-Shan Fu
Jia-Jia Zhang
Wen-Yang Liu
P2860
P304
39727-39735
P356
10.18632/ONCOTARGET.14459
P407
P577
2017-01-03T00:00:00Z